Alx Oncology Holdings (ALXO) insider buying

Healthcare · Biotechnology · Market cap $168M

3 open-market purchases of ALXO by Alx Oncology Holdings's executives and directors since September 2025, worth $5M in total, from SEC Form 4 filings.

The most recent: Corey S Goodman bought $5M on February 2, 2026.

The biggest buyer over the period is Corey S Goodman: 1 purchase, $5M.

By year

YearPurchasesValue
20261$5M
20252$99,401

Biggest buyers

InsiderBuysValue
Corey S Goodman
1$5M
Jason Lettmann
2$99,401

Every purchase

Newest first. From SEC Form 4 filings. Insider buying across the market.

DateInsiderSharesPriceValueFiling
Feb 2, 2026 Corey S Goodman
 3,184,713$1.57$5M Form 4
Sep 17, 2025 Jason Lettmann
 71,163$1.08$76,856 Form 4
Sep 16, 2025 Jason Lettmann
 21,070$1.07$22,545 Form 4
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for ALXO.
Open ALXO in Investingly

Questions

Are Alx Oncology Holdings insiders buying the stock?

3 open-market purchases of ALXO by Alx Oncology Holdings's executives and directors since September 2025, worth $5M in total, from SEC Form 4 filings. The most recent: Corey S Goodman bought $5M on February 2, 2026.

What counts as insider buying here?

Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.

From Alx Oncology Holdings's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.